Lupus nephritis | OMER Message Board Posts

Omeros Corporation

  OMER website

  •  Registered Members of Investor Village:
    Please make sure you are signed in to your Investor Village account to enjoy the full benefits of our service and avoid the MediaPass paywall. If the MediaPass offer page is blocking you, click the light blue "No thanks, take me back" link on the middle right side of the form to get to our home page where you can sign in by entering your Investor Village User Name and Password. 

     MediaPass subscribers: Please make sure you are logged in to your MediaPass subscription to bypass the paywall. You can do this by clicking the light blue "Already have a MediaPass account? Login here" link on the middle left side of the subscription offer form and then entering the email address and password you used when you first signed up with MediaPass.  

    For assistance call 888-222-7309 or email

OMER   /  Message Board  /  Read Message



Rec'd By
Authored By
Minimum Recs
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  2981 of 2987  at  6/20/2020 12:48:40 PM  by


 In response to msg 2980 by  Workinprogress
view thread

Re: Lupus nephritis

Sort of fascinating: AUPH $1.9B cap vs Omer $840B

Has Omer dosed more than 4 Lupus patients? It's hardly mentioned in the most recent 10Q, so not sure how currently-active they are with respect to OMS721 Lupus. Guess we have to wait for the next IgAN readout for more color.

Impressive results from AUPH nonetheless and speed at which they completed the trial. Now deferring to the more knowledgeable members of this board for further comment.

     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 152
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 All rights reserved. User Agreement
Financial Market Data provided by